Saturday, May 23, 2020 1:58:02 PM
Northwest Biotherapeutics Inc (OTCQB:NWBO)Add to Watch ListSet Alert
0.332
Delayed Data
As of May 22
+0.092 / +38.33%
Today’s Change
0.14TODAY
|||
52-Week Range
0.34
+54.49%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Stock Price Forecast
The 1 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 15.10, with a high estimate of 15.10 and a low estimate of 15.10. The median estimate represents a +4,448.19% increase from the last price of 0.33.
Chart unavailable
Analyst Recommendations
The current consensus among 1 polled investment analysts is to hold stock in Northwest Biotherapeutics Inc. This rating has held steady since July, when it was downgraded from a buy rating.
Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current QuarterEarnings per Share
--Sales
--Reporting Date
TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly --
Growthannually 7.50%
Sales
Growthquarterly --
Growthannually 311.00%
Key to the earnings and sales forecast charts.
Search CNN...
U.S
Crime + Justice
Energy + Environment
Extreme Weather
Space + Science
World
Africa
Americas
Asia
Australia
Europe
Middle East
UK
Politics
45
Congress
Supreme Court
2018
Key Races
Primary Results
Business
Markets
Tech
Media
Success
Video
Opinion
Political Op-Eds
Social Commentary
Health
Food
Fitness
Wellness
Parenting
Vital Signs
Entertainment
Stars
Screen
Binge
Culture
Media
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Innovative Cities
Style
Arts
Design
Fashion
Architecture
Luxury
Autos
Video
Travel
Destinations
Food & Drink
Play
Stay
Videos
Sports
Pro Football
College Football
Basketball
Baseball
Soccer
Olympics
Video
Live TV
Digital Studios
CNN Films
HLNTV
Schedule
TV Shows A-Z
CNNVR
Shop
CNN Underscored
-Explore
-Wellness
-Gadgets
-Lifestyle
CNN Store
More...
Photos
Longform
Investigations
CNN Profiles
CNN Leadership
CNN Newsletters
Work for CNN
Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc.2019. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates.
© 2019 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
CNN Sans™ & © 2016 Cable News Network.
Newsletters
Contact Us
Terms of Use
Privacy Policy
Do Not Sell My Personal Information
Accessibiliy & CC
AdChoices
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM